Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer
Clinical trial NCT05932667 · TERMINATED
Trial details
- NCT number
- NCT05932667
- Sponsor
- Institut Curie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-12
- Primary completion
- 2023-11-24
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.